<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39413071</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2767-3375</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PLOS global public health</Title><ISOAbbreviation>PLOS Glob Public Health</ISOAbbreviation></Journal><ArticleTitle>Adopting sustainable innovations for remote access to TB and HIV care in South Africa.</ArticleTitle><Pagination><StartPage>e0003792</StartPage><MedlinePgn>e0003792</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0003792</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgph.0003792</ELocationID><Abstract><AbstractText>For the last decade, South Africa has made substantial progress to control the dual HIV and TB epidemics. However, disruptions in TB and HIV treatment during the COVID-19 pandemic threatened to reverse this. This study aimed to identify adaptations in HIV and TB service delivery models in response to COVID-19 and government restrictions. This information informed the development of an online survey, which was utilized as part of a consultation exercise to further capture adaptations made to HIV/TB service delivery within the South African context. The literature review involved screening 380 titles and abstracts, identifying 30 HIV and TB studies across 19 countries, and categorizing 90 individual interventions into ten thematic areas. Common themes included interventions addressing screening, testing, diagnosis, medication collection and delivery support, and virtual models. Digital health interventions and adaptations to medication collection/delivery were reported in 38% of studies. Analysis of survey responses from 33 stakeholders in South Africa revealed that 47% of interventions targeted HIV, 11% TB, and 23% HIV/TB integrated service delivery. Most interventions (81%) were integrated into the national HIV or TB program, with implementation occurring at various levels: 39% at facility level, 35% at sub-district or district level, and 18% at provincial level. Programmatic data was available for 86% of interventions, with 50% being funded. This study demonstrated that services can be delivered in locations other than in health facilities (e.g., community-based or home-based) and that integrated services can also free up additional resources. Although studies varied, COVID-19 accelerated the adoption of differentiated service delivery (DSD) models for TB care, including multi-month dispensing (MMD) for TB preventative therapy (TPT) and TB treatment, home-based or mobile outreach screening and testing, and community pickup points (PuP) for TB medications. These initiatives had previously lagged behind HIV-focused DSD models, and it is crucial to sustain these services beyond the pandemic. To achieve universal health coverage, it will also be important to capitalize on these experiences and learn from HIV-focused DSD models so programs can deliver integrated person-centered chronic care services for TB, HIV, and non-communicable diseases.</AbstractText><CopyrightInformation>Copyright: © 2024 Galvin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galvin</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2123-5020</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Boston Medical Center (BMC), Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Denise</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0698-1228</Identifier><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moolla</LastName><ForeName>Aneesa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coetzee</LastName><ForeName>Lezanie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maluleke</LastName><ForeName>Vongani</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leshabana</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miot</LastName><ForeName>Jacqui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLOS Glob Public Health</MedlineTA><NlmUniqueID>9918283779606676</NlmUniqueID><ISSNLinking>2767-3375</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39413071</ArticleId><ArticleId IdType="pmc">PMC11482720</ArticleId><ArticleId IdType="doi">10.1371/journal.pgph.0003792</ArticleId><ArticleId IdType="pii">PGPH-D-24-00762</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roy C.M., Bollman E.B., Carson L.M., Northrop A.J., Jackson E.F., &amp; Moresky R.T. (2021). Assessing the indirect effects of COVID-19 on healthcare delivery, utilization and health outcomes: a scoping review. European Journal of Public Health, 31(3), 634–640. doi: 10.1093/eurpub/ckab047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckab047</ArticleId><ArticleId IdType="pmc">PMC8083627</ArticleId><ArticleId IdType="pubmed">33755130</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C.S. (2020). Analysis of COVID-19 cases and public measures in China. SN Comprehensive Clinical Medicine, 2(9), 1306–1312. doi: 10.1007/s42399-020-00426-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00426-6</ArticleId><ArticleId IdType="pmc">PMC7429092</ArticleId><ArticleId IdType="pubmed">32838192</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. [online] Available from https://data.who.int/dashboards/covid19/cases?n=c. Accessed 30 August 2024.</Citation></Reference><Reference><Citation>Haider N., Osman A.Y., Gadzekpo A., Akipede G.O., Asogun D., Ansumana R., et al.. (2020). Lockdown measures in response to COVID-19 in nine sub-Saharan African countries. BMJ Global Health, 5(10), e003319. doi: 10.1136/bmjgh-2020-003319</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-003319</ArticleId><ArticleId IdType="pmc">PMC7542624</ArticleId><ArticleId IdType="pubmed">33028699</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonasar D., Pillay A., Leonard E., Naidoo R., Mngemane S., Ramkrishna W., et al.. (2021). COVID-19: lessons and experiences from South Africa’s first surge. BMJ Global Health, 6(2), e004393. doi: 10.1136/bmjgh-2020-004393</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-004393</ArticleId><ArticleId IdType="pmc">PMC7907826</ArticleId><ArticleId IdType="pubmed">33627361</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin M., Kim A.W., Bosire E., Ndaba N., Cele L., Swana S., et al.. (2023). Community Perceptions and Experiences of the South African Government’s Response to the First Wave of the COVID-19 Pandemic in Johannesburg, South Africa. Social and Health Sciences, 18–pages. 10.25159/2957-3645/12601.</Citation><ArticleIdList><ArticleId IdType="doi">10.25159/2957-3645/12601</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamuzi J.L., Ayele B.T., Shumba C.S., Adetokunboh O.O., Uwimana-Nicol J., Haile Z.T., et al.. (2020). Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence. BMC Infectious Diseases, 20(1), 1–18. doi: 10.1186/s12879-020-05450-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05450-4</ArticleId><ArticleId IdType="pmc">PMC7545798</ArticleId><ArticleId IdType="pubmed">33036570</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay Y., Pienaar S., Barron P., Zondi T. (2021). Impact of COVID-19 on routine primary healthcare services in South Africa. S Afr Med J, 111, 714–9. doi: 10.7196/SAMJ.2021.v111i8.15786</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2021.v111i8.15786</ArticleId><ArticleId IdType="pubmed">35227349</ArticleId></ArticleIdList></Reference><Reference><Citation>Benade M., Long L., Rosen S., Meyer-Rath G., Tucker J.M., &amp; Miot J. (2022. a). Reduction in initiations of HIV treatment in South Africa during the COVID pandemic. BMC Health Services Research, 22(1), 1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970413</ArticleId><ArticleId IdType="pubmed">35361209</ArticleId></ArticleIdList></Reference><Reference><Citation>Benade M., Long L., Meyer-Rath G., Miot J., Evans D., Tucker J.M., et al.. (2022. b). Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data. PLOS Global Public Health, 2(10), e0000559. doi: 10.1371/journal.pgph.0000559</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0000559</ArticleId><ArticleId IdType="pmc">PMC10021649</ArticleId><ArticleId IdType="pubmed">36962535</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimsrud A., Ehrenkranz P., &amp; Sikazwe I. (2021). Silver linings: how COVID‐19 expedited differentiated service delivery for HIV. Journal of the International AIDS Society, 24(Suppl 6), e25807. doi: 10.1002/jia2.25807</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jia2.25807</ArticleId><ArticleId IdType="pmc">PMC8554212</ArticleId><ArticleId IdType="pubmed">34713575</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDSinfo UNAIDS Epidemiological Estimates, 2021. Available from https://aidsinfo.unaids.org/. Accessed 30 August 2024.</Citation></Reference><Reference><Citation>Inzaule S.C., Ondoa P., Loembe M.M., Tebeje Y.K., Ogwell Ouma A.E., Nkengasong J.N. (2021). COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control. PLoS Med, 18(6), e1003666. doi: 10.1371/journal.pmed.1003666</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003666</ArticleId><ArticleId IdType="pmc">PMC8266084</ArticleId><ArticleId IdType="pubmed">34161318</ArticleId></ArticleIdList></Reference><Reference><Citation>Moultrie H., Kachingwe E., Ismail F.
Impact of COVID-19 and public health restrictions on TB testing and case detection in South Africa (2020). National Institute for Communicable Diseases, COVID-19 Special Public Health Surveillance Bulletin, 18 (Supplementary issue 4). Available from https://www.researchgate.net/publication/346396453_Impact_of_Lockdown_on_TB_testing_in_South_Africa/link/5fbf9e65458515b797703b1b/download. Accessed 30 August 2024.</Citation></Reference><Reference><Citation>Osman M., Karat A. S., Khan M., Meehan S. A., von Delft A., Brey Z., et al.. (2021). Health system determinants of tuberculosis mortality in South Africa: a causal loop model. BMC Health Services Research, 21(1), 1–11. doi: 10.1186/s12913-020-05996-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-05996-8</ArticleId><ArticleId IdType="pmc">PMC8074279</ArticleId><ArticleId IdType="pubmed">33902565</ArticleId></ArticleIdList></Reference><Reference><Citation>Green A. (2020). People are scared of COVID-19. And this has caused major disruption to healthcare. City Press. Retrieved from https://www.news24.com/citypress/news/people-arescared-of-covid-19-and-this-has-caused-major-disruptions-to-healthcare-20200720. Accessed 30 August 2024.</Citation></Reference><Reference><Citation>Shange N.
2020. Almost 11,000 HIV-positive patients in Gauteng have skipped ARV collection during lockdown, Timeslive, 19
May 2020. Available from https://www.timeslive.co.za/news/south-africa/2020-05-19-almost-11000-hiv-positive-patients-in-gauteng-have-skipped-arv-collection-during-lockdown/. Accessed 30 August 2024.</Citation></Reference><Reference><Citation>Loveday M., Cox H., Evans D., Furin J., Ndjeka N., Osman M., et al.. (2020). Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa. S Afr Med J, 110(12): 1160–1167. doi: 10.7196/SAMJ.2020.v110i12.15126</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.v110i12.15126</ArticleId><ArticleId IdType="pubmed">33403958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofman K., &amp; Madhi S. (2020). The unanticipated costs of COVID-19 to South Africa’s quadruple disease burden. South African Medical Journal, 110(8), 698–699.</Citation><ArticleIdList><ArticleId IdType="pubmed">32880282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalla-Edward S.T., Mosam A., Hove J., Erzse A., Rwafa-Ponela T., Price J., et al.. (2022). Essential health services delivery in South Africa during COVID-19: Community and healthcare worker perspectives. Frontiers in Public Health, 10, 992481. doi: 10.3389/fpubh.2022.992481</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.992481</ArticleId><ArticleId IdType="pmc">PMC9773136</ArticleId><ArticleId IdType="pubmed">36568767</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukumbang F., Kriel E., van Wyk B., &amp; A Kruger J. (2020). Desperate times call for desperate measures: Adapting antiretroviral service delivery in the context of the COVID-19 pandemic. S Afr Med J, 110(8), 711–712.</Citation><ArticleIdList><ArticleId IdType="pubmed">32880290</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., &amp; Shaman J.L. (2022). COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron). eLife, 11, e78933. Available from Accessed 30 August 2024. doi: 10.7554/eLife.78933</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78933</ArticleId><ArticleId IdType="pmc">PMC9363123</ArticleId><ArticleId IdType="pubmed">35943138</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., &amp; Conde J.G. (2009). A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform, 42(2), 377–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Minor B.L., Elliott V., Fernandez M., O’Neal L., et al.. (2019). The REDCap consortium: building an international community of software platform partners. Journal of Biomedical Informatics, 95, 103208. doi: 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoblauch A.M., de la Rosa S., Sherman J., Blauvelt C., Matemba C., Maxim L., et al.. (2019). Bi-directional drones to strengthen healthcare provision: experiences and lessons from Madagascar, Malawi and Senegal. BMJ Global Health, 4(4), e001541. doi: 10.1136/bmjgh-2019-001541</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2019-001541</ArticleId><ArticleId IdType="pmc">PMC6673761</ArticleId><ArticleId IdType="pubmed">31413873</ArticleId></ArticleIdList></Reference><Reference><Citation>Govender P. (2023). Fibre connectivity is the key to unlocking SA’s potential. Engineering News. Retrieved from https://www.engineeringnews.co.za/article/fibre-connectivity-is-the-key-to-unlocking-sas-potential-2023-06-21. Accessed 30 August 2024.</Citation></Reference><Reference><Citation>Mbunge E., Batani J., Gaobotse G., &amp; Muchemwa B. (2022). Virtual healthcare services and digital health technologies deployed during coronavirus disease 2019 (COVID-19) pandemic in South Africa: a systematic review. Global Health Journal, 6(2), 102–113. doi: 10.1016/j.glohj.2022.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.glohj.2022.03.001</ArticleId><ArticleId IdType="pmc">PMC8897959</ArticleId><ArticleId IdType="pubmed">35282399</ArticleId></ArticleIdList></Reference><Reference><Citation>Amimo F., Lambert B., &amp; Magit A. (2020). What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?. Tropical Medicine and Health, 48, 1–4. doi: 10.1186/s41182-019-0188-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41182-019-0188-z</ArticleId><ArticleId IdType="pmc">PMC7218555</ArticleId><ArticleId IdType="pubmed">32425653</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdool Karim Q., &amp; Baxter C. (2022). COVID-19: impact on the HIV and tuberculosis response, service delivery, and research in South Africa. Current HIV/AIDS Reports, 19(1), 46–53. doi: 10.1007/s11904-021-00588-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11904-021-00588-5</ArticleId><ArticleId IdType="pmc">PMC8783194</ArticleId><ArticleId IdType="pubmed">35064888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lickness J., Bachanas P., Tohme R., Russell A., Craig A., &amp; Hakim A. (2021). COVID-19 mitigation measures to maintain access to essential health services: new opportunities with long-term benefits. Pan African Medical Journal, 40(1), 254. doi: 10.11604/pamj.2021.40.254.31264</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.40.254.31264</ArticleId><ArticleId IdType="pmc">PMC8856970</ArticleId><ArticleId IdType="pubmed">35251448</ArticleId></ArticleIdList></Reference><Reference><Citation>Keene C., Mohr-Holland E., Cassidy T., Scott V., Nelson A., Furin J., et al.. (2020). How COVID-19 could benefit tuberculosis and HIV services in South Africa. The Lancet Respiratory Medicine, 8(9), 844–846. doi: 10.1016/S2213-2600(20)30311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30311-8</ArticleId><ArticleId IdType="pmc">PMC7398675</ArticleId><ArticleId IdType="pubmed">32758439</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutyambizi C., Wilkinson L., Rees K., Moosa S., &amp; Boyles T. (2022). Outcomes of a model integrating tuberculosis testing into COVID-19 services in South Africa. African Journal of Primary Health Care &amp; Family Medicine, 14(1), 1–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9772647</ArticleId><ArticleId IdType="pubmed">36546501</ArticleId></ArticleIdList></Reference><Reference><Citation>Houessinon C., &amp; Magassouba A.S. (2022). Dual testing for TB and SARS-CoV-2: country reports. Available from https://tdr.who.int/docs/librariesprovider10/meeting-reports/dual-testing-for-tb-and-sars-cov-2-country-reports.pdf. Accessed 30 August 2024.</Citation></Reference><Reference><Citation>Grimsrud A., &amp; Wilkinson L. (2021). Acceleration of differentiated service delivery for HIV treatment in sub‐Saharan Africa during COVID‐19. Journal of the International AIDS Society, 24(6), e25704. doi: 10.1002/jia2.25704</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jia2.25704</ArticleId><ArticleId IdType="pmc">PMC8188395</ArticleId><ArticleId IdType="pubmed">34105884</ArticleId></ArticleIdList></Reference><Reference><Citation>Msomi N., Lessells R., Mlisana K., &amp; de Oliveira T. (2021). Africa: tackle HIV and COVID-19 together. Nature, 600(7887), 33–36. doi: 10.1038/d41586-021-03546-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03546-8</ArticleId><ArticleId IdType="pubmed">34853449</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanda-Kapata P., Ntoumi F., Kapata N., Lungu P., Mucheleng’anga L.A., Chakaya J., et al.. (2022). Tuberculosis, HIV/AIDS and malaria health services in sub-Saharan Africa–a situation analysis of the disruptions and impact of the COVID-19 pandemic. International Journal of Infectious Diseases, 124, S41–S46. doi: 10.1016/j.ijid.2022.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8949686</ArticleId><ArticleId IdType="pubmed">35341998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoke T., Bateganya M., Toyo O., Francis C., Shrestha B., Philakone P., et al.. (2021). How home delivery of antiretroviral drugs ensured uninterrupted HIV treatment during COVID-19: experiences from Indonesia, Laos, Nepal, and Nigeria. Global Health: Science and Practice, 9(4), 978–989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691873</ArticleId><ArticleId IdType="pubmed">34933991</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly J., Gittings L., Laurenzi C., Glinski C. D., Mangqalaza H., Ralayo N.,.et al.. (2022). HIV and SRH healthcare delivery experiences of South African healthcare workers and adolescents and young people during COVID-19. Psychology, Health &amp; Medicine, 27(sup1), 155–166. doi: 10.1080/13548506.2022.2108080</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13548506.2022.2108080</ArticleId><ArticleId IdType="pubmed">36004413</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>